|
|
Recently reported Leuprolide Side Effects
Did You Have Leuprolide Side Effect? |
Leuprolide Side Effects Poll Results | ||||||||
|
Vote Below:
|
Have you experienced Leuprolide side effects?
|
Leuprolide Comments and Questions
Join the discussion:
No comments have been provided.
Ask Community about Leuprolide:
What is Your Question? Ask Community:
Daily Health Videos
Leuprolide Side Effects reported on Patientsville.com
None reported at this time.Leuprolide Side Effects reported to FDA
Showing 1-50 of 999 Next >
Leuprolide Side Effects Report #5223683-5Consumer or non-health professional from JAPAN reported Leuprolide side effect on Jan 19, 2007. Female patient, 43 years of age, was diagnosed with endometriosis
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: abdominal distension, ascites, hypersensitivity. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D) SUBCUTANEOUS. Patient recovered.Leuprolide Side Effects Report #5230830-8
Leuprolide side effect was reported by a Consumer or non-health professional from BELGIUM on Jan 29, 2007. Male patient, 74 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: bladder cancer
, sepsis
. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 3 M). During the same period patient was treated with BICALUTAMIDE. Patient was hospitalized. Patient died.Leuprolide Side Effects Report #5234010-1
Consumer or non-health professional from JAPAN reported Leuprolide side effect on Feb 01, 2007. Male patient was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: haematuria, nephrotic syndrome, oedema peripheral, proteinuria. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with BASEN. Patient was hospitalized. Patient recovered.Leuprolide Side Effects Report #5242189-0
Leuprolide side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 02, 2007. Female patient, 36 years of age, was diagnosed with endometriosis
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: arthropathy, condition aggravated, conjunctival haemorrhage, hypotrichosis, joint dislocation, lethargy, pain of skin. Leuprolide dosage: unknown. During the same period patient was treated with TIBOLONE. Patient recovered.Leuprolide Side Effects Report #5242191-9
Consumer or non-health professional from BELGIUM reported Leuprolide side effect on Feb 06, 2007. Male patient, 74 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: bladder cancer
, sepsis
. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 3 M). During the same period patient was treated with BICALUTAMIDE. Patient was hospitalized. Patient died.Leuprolide Side Effects Report #5244028-0
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Feb 07, 2007. Male patient, 86 years of age, was diagnosed with prostate cancer stage iv and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, granuloma, herpes zoster, hot flush, injection site induration, injection site nodule. Leuprolide dosage: 11.25 MG (11.25MG, 1 IN 12 WK); SUBCUTANEOUS. During the same period patient was treated with CASODEX, HARNAL D. Patient was hospitalized. Patient died.
Leuprolide Side Effects Report #5245980-X
Consumer or non-health professional from BELGIUM reported Leuprolide side effect on Feb 14, 2007. Male patient, 85 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: agitation, alanine aminotransferase increased, aspartate aminotransferase increased, atrioventricular block complete, blood lactate dehydrogenase increased, cardiac arrest
, cardiogenic shock, cough, dyskinesia. Leuprolide dosage: unknown. During the same period patient was treated with ZOLEDRONIC ACID, CALCIUM, ERGOCALCIFEROL. Patient was hospitalized. Patient died.Leuprolide Side Effects Report #5246506-7
Leuprolide side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 22, 2007. Male patient, weighting 185.0 lb, was treated with Leuprolide. After drug was administered, patient experienced the following side effects: clavicle fracture, emotional disorder, impaired healing, injury, lower limb fracture, rib fracture, road traffic accident. Leuprolide dosage: 22.5 MG. During the same period patient was treated with CASODEX. Patient recovered.
Leuprolide Side Effects Report #5247989-9
Consumer or non-health professional from JAPAN reported Leuprolide side effect on Feb 19, 2007. Female patient was diagnosed with prostate cancer stage iii and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, cardiac tamponade, cardiomegaly, hepatic function abnormal, lung neoplasm malignant, lymphadenopathy mediastinal, malaise, neck pain. Leuprolide dosage: 11.25 MG, SUBCUTANEOUS, 1 IN 12 WEEKS. During the same period patient was treated with FLUTAMIDE, PLETAAL, JUVELA N, PROCYLIN, DEPAKENE. Patient recovered.
Leuprolide Side Effects Report #5255787-5
Leuprolide side effect was reported by a Consumer or non-health professional from KOREA, REPUBLIC OF on Feb 26, 2007. Male patient, 74 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: hypoxia, pneumonia
, septic shock. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 1 M). During the same period patient was treated with BICALUTAMIDE, CARBAZOCHROME, ZOLEDRONIC ACID. Patient died.Leuprolide Side Effects Report #5259343-4
Consumer or non-health professional from JAPAN reported Leuprolide side effect on Mar 01, 2007. Male patient, 79 years of age, was diagnosed with prostate cancer stage iv and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: pancreatitis acute. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with CASODEX. Patient was hospitalized. Patient recovered.
Leuprolide Side Effects Report #5261749-4
Leuprolide side effect was reported by a Consumer or non-health professional from AUSTRALIA on Mar 02, 2007. Male patient, 70 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: osteonecrosis
. Leuprolide dosage: 22.5 MG (22.5 MG,1 IN 3 M). During the same period patient was treated with ZOLEDRONIC ACID. Patient recovered.Leuprolide Side Effects Report #5264367-7
Consumer or non-health professional from JAPAN reported Leuprolide side effect on Mar 06, 2007. Male patient, 76 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: eczema
, gastritis, inguinal hernia, pneumonia
, renal impairment. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with CASODEX, AMARYL, MAGNESIUM OXIDE HEAVY. Patient was hospitalized. Patient recovered.Leuprolide Side Effects Report #5266710-1
Leuprolide side effect was reported by a Consumer or non-health professional from KOREA, REPUBLIC OF on Mar 08, 2007. Male patient, 74 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: hypoxia, pneumonia
, septic shock. Leuprolide dosage: unknown. During the same period patient was treated with BICALUTAMIDE, CARBAZOCHROME, ZOLEDRONIC ACID. Patient died.Leuprolide Side Effects Report #5269961-5
Consumer or non-health professional from JAPAN reported Leuprolide side effect on Mar 07, 2007. Male patient, 83 years of age, was diagnosed with prostate cancer stage i and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: gastrointestinal carcinoma. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK), SUBCUTANEOUS. During the same period patient was treated with CASODEX. Patient died.
Leuprolide Side Effects Report #5277979-1
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Mar 13, 2007. Male patient, 86 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, brain stem infarction, cerebral circulatory failure, cerebral infarction, eye disorder, eyelid function disorder. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D) SUBCUTANEOUS. During the same period patient was treated with HARNAL D, BLADDERON, TRYPTANOL. Patient was hospitalized. Patient recovered.Leuprolide Side Effects Report #5277983-3
Consumer or non-health professional from JAPAN reported Leuprolide side effect on Mar 15, 2007. Female patient, 36 years of age, was diagnosed with uterine leiomyoma and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D) SUBCUTANEOUS. Patient was hospitalized. Patient recovered.
Leuprolide Side Effects Report #5277987-0
Leuprolide side effect was reported by a Consumer or non-health professional from AUSTRALIA on Mar 12, 2007. Male patient, 70 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: osteonecrosis
. Leuprolide dosage: 22.5 MG (22.5 MG, 1 IN 3 M) INTRAMUSCULAR. During the same period patient was treated with ZOLEDRONIC ACID. Patient recovered.Leuprolide Side Effects Report #5281073-3
Consumer or non-health professional from JAPAN reported Leuprolide side effect on Mar 16, 2007. Male patient, 81 years of age, was diagnosed with prostate cancer stage ii and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: cerebrovascular disorder. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with LEUPROLIDE ACETATE, CASODEX, NEUQUINON. Patient was hospitalized. Patient recovered.
Leuprolide Side Effects Report #5282645-2
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Mar 21, 2007. Male patient, 77 years of age, was diagnosed with prostate cancer stage iii and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: condition aggravated, interstitial lung disease. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK). During the same period patient was treated with CASODEX, PREDNISOLONE, OMEPRAL, GASTROM. Patient was hospitalized. Patient died.
Leuprolide Side Effects Report #5284334-7
Consumer or non-health professional from JAPAN reported Leuprolide side effect on Mar 23, 2007. Male patient, 76 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: eczema
, gastritis, haematuria, inguinal hernia, nephropathy, pneumonia
, proteinuria, renal impairment. Leuprolide dosage: 11.25 MG, SUBCUTANEOUS. During the same period patient was treated with CASODEX, AMARYL, MAGNESIUM OXIDE HEAVY, LENDORMIN D. Patient was hospitalized. Patient recovered.Leuprolide Side Effects Report #5290669-4
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Mar 26, 2007. Male patient, 76 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: oral mucosa erosion, stevens-johnson syndrome. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D) SUBCUTANEOUS. During the same period patient was treated with CHLORMADINONE ACETATE, MAGLAX, LIPOVAS, FLIVAS. Patient recovered.Leuprolide Side Effects Report #5293599-7
Consumer or non-health professional from JAPAN reported Leuprolide side effect on Apr 02, 2007. Male patient, 81 years of age, was diagnosed with prostate cancer stage ii and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: cerebrovascular disorder. Leuprolide dosage: 11.25 MG (11;25 MG, 1 IN 12 WK); SUBCUTANEOUS. During the same period patient was treated with LEUPROLIDE ACETATE, CASODEX, NEUQUINON. Patient was hospitalized. Patient recovered.
Leuprolide Side Effects Report #5296198-6
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Apr 04, 2007. Male patient, 79 years of age, was diagnosed with prostate cancer stage iv and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: pancreatitis acute. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with CASODEX. Patient was hospitalized. Patient recovered.
Leuprolide Side Effects Report #5297446-9
Consumer or non-health professional from GERMANY reported Leuprolide side effect on Apr 03, 2007. Male patient, 81 years of age, was treated with Leuprolide. After drug was administered, patient experienced the following side effects: dental caries. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 3 M) SUBCUTANEOUS. Patient recovered.
Leuprolide Side Effects Report #5297761-9
Leuprolide side effect was reported by a Consumer or non-health professional from GERMANY on Apr 03, 2007. Male patient, 73 years of age, was treated with Leuprolide. After drug was administered, patient experienced the following side effects: dental caries. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 3 M) SUBCUTANEOUS. Patient recovered.
Leuprolide Side Effects Report #5305623-3
Consumer or non-health professional from UNITED STATES reported Leuprolide side effect on Apr 19, 2007. Male patient, weighting 207.2 lb, was treated with Leuprolide. After drug was administered, patient experienced the following side effects: diabetes mellitus, dysuria, urinary retention. Leuprolide dosage: 30 MG. During the same period patient was treated with CASODEX. Patient recovered.
Leuprolide Side Effects Report #5313736-5
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Apr 23, 2007. Male patient, 81 years of age, was diagnosed with prostate cancer stage iv and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: cerebral infarction, prostatic specific antigen increased. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK, SUBCUTANEOUS. During the same period patient was treated with CASODEX. Patient died.
Leuprolide Side Effects Report #5314693-8
Consumer or non-health professional from JAPAN reported Leuprolide side effect on Apr 24, 2007. Male patient, 77 years of age, was diagnosed with prostate cancer stage iii and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: condition aggravated, infection
, interstitial lung disease. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with CASODEX, PREDNISOLONE, OMEPRAL. Patient was hospitalized. Patient died.Leuprolide Side Effects Report #5324327-4
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on May 07, 2007. Female patient was diagnosed with uterine leiomyoma and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: reversible posterior leukoencephalopathy syndrome. Leuprolide dosage: unknown. Patient was hospitalized. Patient recovered.
Leuprolide Side Effects Report #5326868-2
Consumer or non-health professional from AUSTRALIA reported Leuprolide side effect on May 08, 2007. Male patient, 70 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: osteomyelitis, osteonecrosis
, pain in jaw. Leuprolide dosage: 22.5 MG (22.5 MG, 1 IN 1 3M); INTRAMUSCULAR. During the same period patient was treated with ZOLEDRONIC ACID. Patient recovered.Leuprolide Side Effects Report #5326869-4
Leuprolide side effect was reported by a Consumer or non-health professional from GERMANY on May 08, 2007. Female patient, child 7 years of age, was diagnosed with precocious puberty and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: abdominal pain
, chills, convulsion, dermatitis allergic, diplopia, erythema, injection site erythema, injection site pain, injection site swelling. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 1 M), SUBCUTANEOUS. During the same period patient was treated with LAMICTAL, PRIMIDONE. Patient was hospitalized. Patient recovered.Leuprolide Side Effects Report #5328170-1
Consumer or non-health professional from JAPAN reported Leuprolide side effect on May 10, 2007. Male patient, 78 years of age, was diagnosed with prostate cancer stage ii and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: cardiac failure acute, fall
. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with CHLORMADINONE ACETATE, CERNILTON, URIEF. Patient died.Leuprolide Side Effects Report #5332500-4
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on May 17, 2007. Male patient, 77 years of age, was diagnosed with prostate cancer stage iii and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: adenocarcinoma, aspartate aminotransferase increased, blood alkaline phosphatase increased, cardiac tamponade, cardiomegaly, hepatic function abnormal, lung neoplasm malignant, lymphadenopathy mediastinal, malaise. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK). During the same period patient was treated with FLUTAMIDE, PLETAAL, JUVELA N, PROCYLIN, DEPAKENE. Patient recovered.
Leuprolide Side Effects Report #5337139-2
Consumer or non-health professional from JAPAN reported Leuprolide side effect on May 21, 2007. Male patient, 81 years of age, was diagnosed with prostate cancer stage iv and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: cerebral infarction. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with CASODEX. Patient died.
Leuprolide Side Effects Report #5339501-0
Leuprolide side effect was reported by a Consumer or non-health professional from AUSTRALIA on May 21, 2007. Male patient, 87 years of age, was treated with Leuprolide. After drug was administered, patient experienced the following side effects: depression
, erectile dysfunction
, fatigue, memory impairment, meningitis
, pollakiuria, urinary incontinence
. Leuprolide dosage: unknown. Patient was hospitalized. Patient recovered.Leuprolide Side Effects Report #5339502-2
Consumer or non-health professional from FRANCE reported Leuprolide side effect on May 22, 2007. Male patient, 80 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: cerebrovascular accident, condition aggravated, multiple myeloma
. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 3 M) SUBCUTANEOUS. During the same period patient was treated with FLUTAMIDE. Patient died.Leuprolide Side Effects Report #5340058-9
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on May 22, 2007. Male patient was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: infection in an immunocompromised host, interstitial lung disease, respiratory failure. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D) SUBCUTANEOUS. Patient died.Leuprolide Side Effects Report #5345731-4
Consumer or non-health professional from JAPAN reported Leuprolide side effect on May 29, 2007. Male patient, 79 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: cardiac arrest
, condition aggravated, haemolysis, hyperkalaemia, myocardial infarction. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D); SUBCUTANEOUS. During the same period patient was treated with LOXONIN, MUCOSTA, ALLOID G, GASMOTIN. Patient died.Leuprolide Side Effects Report #5345749-1
Leuprolide side effect was reported by a Consumer or non-health professional from FRANCE on May 30, 2007. Male patient, 70 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: laryngeal haemorrhage, lung infection, shock. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 3 M); SUBCUTANEOUS. During the same period patient was treated with FLUTAMIDE. Patient was hospitalized. Patient died.Leuprolide Side Effects Report #5347029-7
Consumer or non-health professional from JAPAN reported Leuprolide side effect on Mar 29, 2007. Female patient, 44 years of age, was diagnosed with uterine leiomyoma and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: cyanosis. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D) SUBCUTANEOUS. Patient recovered.
Leuprolide Side Effects Report #5353027-X
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on June 04, 2007. Male patient, 77 years of age, was diagnosed with prostate cancer stage iii and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, cardiac tamponade, lung adenocarcinoma, lung neoplasm malignant, lymphadenopathy mediastinal, neck pain, oedema peripheral, pericardial effusion. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with FLUTAMIDE, PLETAAL, JUVELA N, PROCYLIN, DEPAKENE. Patient recovered.
Leuprolide Side Effects Report #5355192-7
Consumer or non-health professional from JAPAN reported Leuprolide side effect on May 29, 2007. Male patient, 79 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with FLIVAS. Patient died.Leuprolide Side Effects Report #5362670-3
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on June 11, 2007. Male patient, 79 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: bedridden, blood chloride decreased, blood creatine phosphokinase increased, blood creatinine decreased, blood ketone body increased, blood sodium decreased, blood urea increased, cardiac arrest
, cardiac failure acute. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D), SUBCUTANEOUS. During the same period patient was treated with LOXONIN, MUCOSTA, AMIGRAND, VITAMEDIN, ASCORBIC ACID, SOLUTIONS PARENTERAL NUTRITION. Patient died.Leuprolide Side Effects Report #5362673-9
Consumer or non-health professional from JAPAN reported Leuprolide side effect on June 12, 2007. Female patient, 45 years of age, was diagnosed with endometriosis
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: abdominal pain lower, acute abdomen, anorexia, ascites, genital haemorrhage, intestinal obstruction, intestinal perforation, intestinal stenosis, nausea
. Leuprolide dosage: 1.88 MG (1.88 MG, 1 IN 28 D), SUBCUTANEOUS. During the same period patient was treated with LEUPROLIDE ACETATE. Patient was hospitalized. Patient recovered.Leuprolide Side Effects Report #5363115-X
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on June 12, 2007. Male patient was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: immunosuppression, interstitial lung disease, respiratory failure. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D) SUBCUTANEOUS. Patient died.Leuprolide Side Effects Report #5363118-5
Consumer or non-health professional from AUSTRALIA reported Leuprolide side effect on June 12, 2007. Male patient, 86 years of age, was treated with Leuprolide. After drug was administered, patient experienced the following side effects: asthenia, coordination abnormal, depression
, erectile dysfunction
, exercise tolerance decreased, fatigue, loss of consciousness, malaise, memory impairment. Leuprolide dosage: unknown. Patient was hospitalized. Patient recovered.Leuprolide Side Effects Report #5368355-1
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on June 14, 2007. Male patient, 68 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: interstitial lung disease, pulmonary alveolar haemorrhage. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D) SUBCUTANEOUS. During the same period patient was treated with CASODEX, HARNAL, MYSLEE. Patient was hospitalized. Patient died.Leuprolide Side Effects Report #5368366-6
Consumer or non-health professional from JAPAN reported Leuprolide side effect on June 13, 2007. Male patient, 72 years of age, was treated with Leuprolide. After drug was administered, patient experienced the following side effects: cataract
. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with CASODEX, ATELEC, CARVACRON, OLMETEC, PURSENNID. Patient recovered.Leuprolide Side Effects Report #5369061-X
Leuprolide side effect was reported by a Consumer or non-health professional from FRANCE on June 13, 2007. Male patient, 81 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 3 M) SUBCUTANEOUS. During the same period patient was treated with FLUTAMIDE. Patient died.Showing 1-50 of 999 Next >
Advise and Guidance
Dementia and Pilot study provides new insight on effect of ginkgo extract on dementia
Leuprolide Side Effects

